Home/Filings/4/0001549084-23-000045
4//SEC Filing

Jones Jason C 4

Accession 0001549084-23-000045

CIK 0001549084other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 9:59 PM ET

Size

12.5 KB

Accession

0001549084-23-000045

Insider Transaction Report

Form 4
Period: 2021-01-28
Jones Jason C
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2021-01-28+1,1451,145 total(indirect: By 401(k))
  • Award

    Common Stock

    2023-06-12+10,80015,291 total(indirect: By 401(k))
  • Award

    Common Stock

    2023-06-12+20,000158,554 total
  • Award

    Common Stock

    2023-06-12+170,454329,008 total
  • Award

    Common Stock

    2022-02-17+3,3464,491 total(indirect: By 401(k))
Footnotes (5)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
  • [F2]The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 8, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
  • [F3]Includes 80,867 unvested RSUs.
  • [F4]The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of January 3, 2024, 2025 and 2026, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
  • [F5]Includes 251,141 unvested RSUs.

Issuer

EKSO BIONICS HOLDINGS, INC.

CIK 0001549084

Entity typeother

Related Parties

1
  • filerCIK 0001775619

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:59 PM ET
Size
12.5 KB